Timeline

Véronique Mayau
Technician
01 Jan 2023
publication

Sec61 blockade therapy overrides resistance to proteasome inhibitors and immunomodulatory drugs in multiple myeloma.

Read more
07 Mar 2022
publication

The Sec61 translocon is a therapeutic vulnerability in multiple myeloma.

Read more
11 Jan 2022
news

New publication – The Sec61 translocon is a therapeutic vulnerability in multiple myeloma

Read more
24 Dec 2021
publication

De novo synthesized polyunsaturated fatty acids operate as both host immunomodulators and nutrients for Mycobacterium tuberculosis.

Read more
24 Sep 2020
publication

Dysregulation of tryptophan catabolism at the host-skin microbiota interface in Hidradenitis Suppurativa.

Read more